STOCK TITAN

ALLURION TECHNOLOGIES WTS 8-K Filings

ALURW OTC

Every 8-K that ALLURION TECHNOLOGIES WTS (ALURW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow ALURW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALURW filings page.

Rhea-AI Summary

Allurion Technologies, Inc. (ALUR) reports the resignation of two directors and a reduction in board size. On August 17, 2026, Krishna Gupta, a Class I director and member of the Nominating and Corporate Governance Committee, resigned from the board and that committee. On August 19, 2026, Michael Davin, a Class III director, resigned from the board and from his roles as Chairman of the Compensation Committee and member of the Audit Committee. In connection with these departures, the board approved a reduction in its size from five members to three members.

Rhea-AI Summary

Allurion Technologies, Inc. entered into an exchange agreement with RTW-affiliated stockholders on July 21, 2026, under which they exchanged an aggregate of 392,766 shares of common stock for pre-funded warrants to purchase an equal number of shares. The warrants have a $0.0001 per share exercise price, are immediately exercisable, and include a beneficial ownership limitation initially set at 9.99% of outstanding common stock, adjustable up to 19.99% upon 61 days’ written notice.

Each warrant will automatically terminate upon foreclosure on collateral securing Allurion’s Revenue Interest Financing Agreements or its 6% Convertible Secured Notes due 2031, upon specified bankruptcy events, or at the holder’s election. Affiliates of RTW Investments, LP, which hold these instruments, beneficially owned approximately 38% of Allurion’s outstanding common stock prior to the exchange. Allurion also received notice terminating a November 11, 2025 Securities Purchase and Exchange Agreement that would have exchanged certain indebtedness for Series B Perpetual Convertible Preferred Stock; because closing did not occur by February 28, 2026, the agreement became void with no termination penalty, and the related indebtedness, including amounts under the revenue interest agreements and convertible notes, remains outstanding on its original terms. The exchange relied on the Section 3(a)(9) exemption for transactions with existing security holders.

Rhea-AI Summary

Allurion Technologies, Inc. stated that Chief Executive Officer and board member Shantanu K. Gaur, M.D. resigned his positions effective immediately on July 17, 2026. The company reported that his resignation was not the result of any disagreement regarding operations, policies or practices.

The board of directors has not appointed an interim or permanent Chief Executive Officer. Chief Operating Officer Ojas Buch is overseeing day-to-day operations and certain responsibilities previously performed by Dr. Gaur, while his title and compensation arrangements remain unchanged.

Rhea-AI Summary

Allurion Technologies, Inc. reported that director Douglas Hudson, a Class II member of the board, resigned from the board and from the Nominating and Corporate Governance Committee effective June 30, 2026. The company stated that his resignation was not due to any disagreement with management, the board, or company policies or practices. The board is evaluating which current director will be appointed to replace him on the Nominating and Corporate Governance Committee.

Rhea-AI Summary

Allurion Technologies, Inc. reported that R. Jason Richey, a Class II member of its board of directors, resigned from the board and as chairperson of the Audit Committee on June 24, 2026. The company states that his resignation did not result from any disagreement with management, the board, or any matter relating to operations, policies, or practices. The board is evaluating which of its directors will succeed him as Audit Committee chair.

Rhea-AI Summary

Allurion Technologies is implementing a 1-for-15 reverse stock split of its common stock to support its plan to regain listing on a national securities exchange such as the NYSE or NYSE American. The split becomes effective at 12:01 a.m. Eastern Time on June 18, 2026, after which every 15 issued or outstanding shares will be combined into one share without changing par value.

This will reduce the number of outstanding shares of common stock from approximately 15,006,253 to approximately 1,000,417, with fractional positions rounded up to the next whole share. The stock will trade on a split-adjusted basis on the OTCQB under the temporary symbol “ALURD” for about 20 trading days before reverting to “ALUR.”

All equity incentive awards, options, RSUs, convertible notes and warrants, including public warrants, will be proportionally adjusted. Each public warrant trading as “ALUR WS” will become exercisable for 0.00378787 shares of common stock at an exercise price of $3,037.50 per share, reflecting the 15-to-1 reverse split ratio.

Rhea-AI Summary

Allurion Technologies, Inc. reported a change in its external auditor and reiterated previously disclosed weaknesses in its financial controls. The Audit Committee dismissed Deloitte & Touche LLP as independent registered public accounting firm effective May 22, 2026, after Deloitte had audited the company since 2016. Deloitte’s reports on the fiscal years ended December 31, 2024 and 2025 contained no adverse opinions or qualifications, and the company states there were no disagreements with Deloitte on accounting, disclosure, or audit scope.

The company did, however, report material weaknesses in internal control over financial reporting for 2024, 2025 and the interim period through May 22, 2026. These relate to insufficient segregation of duties in the close process, inadequate staffing with public company and technical accounting expertise, and insufficient information systems controls around access and change management. On May 20, 2026, the Audit Committee appointed CBIZ CPAs P.C. as the new independent registered public accounting firm for the fiscal year ending December 31, 2026.